These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33538413)

  • 21. Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial.
    Sandborn WJ; Panés J; Danese S; Sharafali Z; Hassanali A; Jacob-Moffatt R; Eden C; Daperno M; Valentine JF; Laharie D; Baía C; Atreya R; Panaccione R; Rydzewska G; Aguilar H; Vermeire S;
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):43-55. PubMed ID: 36240801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of medical hypnosis for pain reduction and faster wound healing in pediatric acute burn injury: study protocol for a randomized controlled trial.
    Chester SJ; Stockton K; De Young A; Kipping B; Tyack Z; Griffin B; Chester RL; Kimble RM
    Trials; 2016 Apr; 17(1):223. PubMed ID: 27129580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose naltrexone for induction of remission in Crohn's disease.
    Parker CE; Nguyen TM; Segal D; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010410. PubMed ID: 29607497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition.
    Afzal NA; Van Der Zaag-Loonen HJ; Arnaud-Battandier F; Davies S; Murch S; Derkx B; Heuschkel R; Fell JM
    Aliment Pharmacol Ther; 2004 Jul; 20(2):167-72. PubMed ID: 15233696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn's Disease: a Pilot Randomized Placebo-Controlled Trial.
    Mikocka-Walus A; Hughes PA; Bampton P; Gordon A; Campaniello MA; Mavrangelos C; Stewart BJ; Esterman A; Andrews JM
    J Crohns Colitis; 2017 Apr; 11(4):509-514. PubMed ID: 27664274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosocial interventions for conversion and dissociative disorders in adults.
    Ganslev CA; Storebø OJ; Callesen HE; Ruddy R; Søgaard U
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD005331. PubMed ID: 32681745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-Reported Outcomes Measurement Information System in Children with Crohn's Disease.
    Arvanitis M; DeWalt DA; Martin CF; Long MD; Chen W; Jaeger B; Sandler RS; Kappelman MD
    J Pediatr; 2016 Jul; 174():153-159.e2. PubMed ID: 27157449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
    Urlep D; Benedik E; Brecelj J; Orel R
    Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome: A Randomized Clinical Trial.
    Rutten JMTM; Vlieger AM; Frankenhuis C; George EK; Groeneweg M; Norbruis OF; Tjon A Ten W; van Wering HM; Dijkgraaf MGW; Merkus MP; Benninga MA
    JAMA Pediatr; 2017 May; 171(5):470-477. PubMed ID: 28346581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypnosis as a treatment of chronic widespread pain in general practice: a randomized controlled pilot trial.
    Grøndahl JR; Rosvold EO
    BMC Musculoskelet Disord; 2008 Sep; 9():124. PubMed ID: 18801190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
    Danese S; Vermeire S; D'Haens G; Panés J; Dignass A; Magro F; Nazar M; Le Bars M; Lahaye M; Ni L; Bravata I; Lavie F; Daperno M; Lukáš M; Armuzzi A; Löwenberg M; Gaya DR; Peyrin-Biroulet L;
    Lancet Gastroenterol Hepatol; 2022 Apr; 7(4):294-306. PubMed ID: 35120656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Joint involvement, disease activity and quality of life in pediatric Crohn's disease - a cross-sectional study.
    Derfalvi B; Boros KK; Szabo D; Bozsaki G; Cseh A; Rudas G; Muller KE; Veres G
    Pediatr Rheumatol Online J; 2022 Jan; 20(1):6. PubMed ID: 35093127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brief telephone-delivered cognitive behavioral therapy targeted to parents of children with functional abdominal pain: a randomized controlled trial.
    Levy RL; Langer SL; van Tilburg MAL; Romano JM; Murphy TB; Walker LS; Mancl LA; Claar RL; DuPen MM; Whitehead WE; Abdullah B; Swanson KS; Baker MD; Stoner SA; Christie DL; Feld AD
    Pain; 2017 Apr; 158(4):618-628. PubMed ID: 28301859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease.
    Lix LM; Graff LA; Walker JR; Clara I; Rawsthorne P; Rogala L; Miller N; Ediger J; Pretorius T; Bernstein CN
    Inflamm Bowel Dis; 2008 Nov; 14(11):1575-84. PubMed ID: 18512245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study.
    Smith JP; Field D; Bingaman SI; Evans R; Mauger DT
    J Clin Gastroenterol; 2013 Apr; 47(4):339-45. PubMed ID: 23188075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
    Loftus EV; Feagan BG; Colombel JF; Rubin DT; Wu EQ; Yu AP; Pollack PF; Chao J; Mulani P
    Am J Gastroenterol; 2008 Dec; 103(12):3132-41. PubMed ID: 18853973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
    Pittet VEH; Maillard MH; Simonson T; Fournier N; Rogler G; Michetti P;
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2050-2059.e1. PubMed ID: 30471455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-hypnosis for management of chronic dyspnea in pediatric patients.
    Anbar RD
    Pediatrics; 2001 Feb; 107(2):E21. PubMed ID: 11158495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adalimumab for induction of remission in Crohn's disease.
    Abbass M; Cepek J; Parker CE; Nguyen TM; MacDonald JK; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized controlled trial of hypnosis compared with biofeedback for adults with chronic low back pain.
    Tan G; Rintala DH; Jensen MP; Fukui T; Smith D; Williams W
    Eur J Pain; 2015 Feb; 19(2):271-80. PubMed ID: 24934738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.